Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO) Pilot Randomized Trial

NCT05733416 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT05733416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05733416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO) Pilot Randomized Trial
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2023
Completion date
January 31, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

occult cancer